These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 35170396)
1. Cannabis and Mental Health: Adverse Outcomes and Self-Reported Impact of Cannabis Use by Mental Health Status. Rup J; Freeman TP; Perlman C; Hammond D Subst Use Misuse; 2022; 57(5):719-729. PubMed ID: 35170396 [No Abstract] [Full Text] [Related]
2. Cannabis and mental health: Prevalence of use and modes of cannabis administration by mental health status. Rup J; Freeman TP; Perlman C; Hammond D Addict Behav; 2021 Oct; 121():106991. PubMed ID: 34087766 [TBL] [Abstract][Full Text] [Related]
3. Adverse outcomes of cannabis use in Canada, before and after legalisation of non-medical cannabis: cross-sectional analysis of the International Cannabis Policy Study. Marquette A; Iraniparast M; Hammond D BMJ Open; 2024 Jan; 14(1):e077908. PubMed ID: 38171626 [TBL] [Abstract][Full Text] [Related]
4. Self-reported Impact of the COVID-19 Pandemic on Cannabis Use in Canada and the United States. Wadsworth E; Goodman S; Hammond D J Psychoactive Drugs; 2023; 55(4):483-492. PubMed ID: 35981105 [TBL] [Abstract][Full Text] [Related]
5. Prevalence and self-reported reasons of cannabis use for medical purposes in USA and Canada. Leung J; Chan G; Stjepanović D; Chung JYC; Hall W; Hammond D Psychopharmacology (Berl); 2022 May; 239(5):1509-1519. PubMed ID: 35020045 [TBL] [Abstract][Full Text] [Related]
6. A cross-sectional study of the relationship between frequency of cannabis use and psychiatric symptoms among people seeking mental health and addiction services in Nova Scotia (2019-21). Yang L; Tibbo PG; Stewart SH; Simon P; Bullerwell M; Wang J J Psychiatr Res; 2024 May; 173():104-110. PubMed ID: 38518571 [TBL] [Abstract][Full Text] [Related]
7. Mental Health and Medical Cannabis Use among Youth and Young Adults in Canada. Wadsworth E; Leos-Toro C; Hammond D Subst Use Misuse; 2020; 55(4):582-589. PubMed ID: 31747851 [No Abstract] [Full Text] [Related]
8. Use of cannabis for mental health in the Canadian territories: a cross-sectional study. Schwartz N; Poon T; Hammond D; Hobin E Subst Use Misuse; 2025; 60(1):74-82. PubMed ID: 39344143 [TBL] [Abstract][Full Text] [Related]
9. Home cultivation across Canadian provinces after cannabis legalization. Wadsworth E; Cristiano N; Pacheco K; Jesseman R; Hammond D Addict Behav Rep; 2022 Jun; 15():100423. PubMed ID: 35434251 [TBL] [Abstract][Full Text] [Related]
10. Consumer perceptions of legal cannabis products in Canada, 2019-2021: a repeat cross-sectional study. Wadsworth E; Fataar F; Goodman S; Smith DM; Renard J; Gabrys R; Jesseman R; Hammond D BMC Public Health; 2022 Nov; 22(1):2048. PubMed ID: 36348479 [TBL] [Abstract][Full Text] [Related]
11. Racial and Ethnic Differences in Cannabis Use Following Legalization in US States With Medical Cannabis Laws. Martins SS; Segura LE; Levy NS; Mauro PM; Mauro CM; Philbin MM; Hasin DS JAMA Netw Open; 2021 Sep; 4(9):e2127002. PubMed ID: 34570205 [TBL] [Abstract][Full Text] [Related]
12. Prevalence and modes of cannabis use among youth in Canada, England, and the US, 2017 to 2019. Hammond D; Wadsworth E; Reid JL; Burkhalter R Drug Alcohol Depend; 2021 Feb; 219():108505. PubMed ID: 33421799 [TBL] [Abstract][Full Text] [Related]
13. Venus and Mars on the benches of the faculty: Influence of gender on mental health and behavior of medical students. Results from the BOURBON national study. Fond G; Bourbon A; Auquier P; Micoulaud-Franchi JA; Lançon C; Boyer L J Affect Disord; 2018 Oct; 239():146-151. PubMed ID: 30005328 [TBL] [Abstract][Full Text] [Related]
14. Psychiatric and psychological follow-up of undergraduate and postgraduate medical students: Prevalence and associated factors. Results from the national BOURBON study. Fond G; Bourbon A; Lançon C; Boucekine M; Micoulaud-Franchi JA; Auquier P; Boyer L Psychiatry Res; 2019 Feb; 272():425-430. PubMed ID: 30611959 [TBL] [Abstract][Full Text] [Related]
15. Perceptions of the health risks of cannabis: estimates from national surveys in Canada and the United States, 2018-2019. Goodman S; Hammond D Health Educ Res; 2022 Mar; 37(2):61-78. PubMed ID: 35311986 [TBL] [Abstract][Full Text] [Related]
16. Cannabis use behaviors and prevalence of anxiety and depressive symptoms in a cohort of Canadian medicinal cannabis users. Turna J; Simpson W; Patterson B; Lucas P; Van Ameringen M J Psychiatr Res; 2019 Apr; 111():134-139. PubMed ID: 30738930 [TBL] [Abstract][Full Text] [Related]
17. Co-occurrence across time and space of drug- and cannabinoid- exposure and adverse mental health outcomes in the National Survey of Drug Use and Health: combined geotemporospatial and causal inference analysis. Reece AS; Hulse GK BMC Public Health; 2020 Nov; 20(1):1655. PubMed ID: 33148213 [TBL] [Abstract][Full Text] [Related]
18. Predictors of perceived symptom change with acute cannabis use for mental health conditions in a naturalistic sample: A machine learning approach. Kuhathasan N; Ballester PL; Minuzzi L; MacKillop J; Frey BN Compr Psychiatry; 2023 Apr; 122():152377. PubMed ID: 36787672 [TBL] [Abstract][Full Text] [Related]
19. [Search association between cannabis abuse and bipolar disorder: A study on a sample of patients hospitalized for bipolar disorder]. Kazour F; Awaida C; Souaiby L; Richa S Encephale; 2018 Feb; 44(1):14-21. PubMed ID: 27745717 [TBL] [Abstract][Full Text] [Related]
20. Noticing of cannabis health warning labels in Canada and the US. Goodman S; Hammond D Health Promot Chronic Dis Prev Can; 2021; 41(7-8):201-210. PubMed ID: 34427418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]